GlassScriptPhysician profile
Daniel David Douglass
NPI 1932678398
$563.43
in general payments reported to CMS, 2019-2025
8 companies · $19.07 in 2025
The $19.07 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $455 · 2024: $89.78 · 2025: $19.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $563.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genmab U.S., INC. | $144.17 | 2023 | Epkinly |
| Janssen Biotech, INC. | $102.91 | 2023 | Darzalex, Tecvayli, Carvykti |
| Seagen INC. | $94.23 | 2023 | Padcev |
| Glaxosmithkline, LLC. | $89.78 | 2024 | Ojjaara |
| Puma Biotechnology, INC. | $74.31 | 2023 | |
| Novartis Pharmaceuticals Corporation | $23.95 | 2023 | |
| Gilead Sciences, INC. | $19.07 | 2025 | |
| Genentech USA, INC. | $15.01 | 2023 | Lunsumio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Douglass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.